Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...

The Mullen Group: One of North America’s largest logistic providers

Welcome to the Market Herald “Learn & Earn” Video Q&A Podcast. I’m Simon Druker. Meet the company that’s driving diversity, stability, and reliability in the critical transportation, and...

ConocoPhillips (COP): Playing the crack spread

There’s a lot of talk about diversification and asset allocation on this website, and rightly so. While diversification can limit large short-term gains, it also protects against large short-term losses. Since the markets tend to be unpredictable, it&CloseC...

Copper price's fall from 2022 highs might only be temporary

The copper story has had its ups and downs. Currently it’s trading at around US$3.80. Copper’s high point came in March 2022 at US$5.02 a pound. With optimism on higher prices at the start of the year, expectations have not been met as Chi...

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...

Science FACT: The Future of Food is Here…Today

Welcome to the future of food science…happening right now. CULT Food Science Corp. ( CSE.CULT , OTCQB:CULTF , Forum ) is an innovative platform advancing the future of food with an exclusive focus on cultivated meat, cultured dairy, and cell-based foods. The first...

Johnson & Johnson, Memphasys, Procter & Gamble - for a better life

Good health is a valuable possession. Small and large companies around the globe are engaged in research and development to make people's lives easier or better through modern and innovative products and solutions. The consumer goods and pharmaceutical sectors often offer attr...

New proposal puts Macarthur Minerals’ (ASX:MIO) rail link on track

Macarthur Minerals (MMS) has received a key proposal, regarding its planned rail link at the Lake Giles Iron Project in Western Australia’s Yilgarn Region Through the proposal, Macarthur Minerals and Arc Infrastructure will begin developing a commerc...

XPhyto Announces a PCR Testing Breakthrough

It’s the technological breakthrough that the world has been waiting for. A small Canadian life sciences company, XPhyto Therapeutics Corp. ( CSE:XPHY ) (FSE:4XT), has just announced its ability to significantly speed up testing for COVID-19 in an...
1 2 3 4 5 6 7